JP Patent

JP2014097964A — 重水素化されたｃｆｔｒ増強物質

Assigned to Concert Pharmaceuticals Inc · Expires 2014-05-29 · 12y expired

What this patent protects

【課題】新規イバカフトル（ivacaftor）誘導体、およびその薬学的に許容される塩の提供。【解決手段】式Iの重水素修飾化合物：【選択図】なし

USPTO Abstract

【課題】新規イバカフトル（ivacaftor）誘導体、およびその薬学的に許容される塩の提供。【解決手段】式Iの重水素修飾化合物：【選択図】なし

Drugs covered by this patent

Patent Metadata

Patent number: JP2014097964A
Jurisdiction: JP
Classification: —
Expires: 2014-05-29
Drug substance claim: No
Drug product claim: No
Assignee: Concert Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.